Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer

By Fidan Evren  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1519-1525

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer

By Masago Katsuhiro  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 351-356

Humana Press, Inc

Access to resources Recommend Favorite

Soluble Urokinase Plasminogen Activator Receptor in Preoperatively Obtained Plasma from Patients with Gynecological Cancer or Benign Gynecological Diseases

By Riisbro R.   Stephens R.W.   Brunner N.   Christensen I.J.   Nielsen H.J.   Heilmann L.   von Tempelhoff G.-F.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 523-531

Elsevier

Access to resources Recommend Favorite

Elevated preoperative plasma Ddimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer

By              

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 299-304

Spandidos Publications

Access to resources Recommend Favorite

Fatty Acid Composition of Lysophosphatidic Acid and Lysophosphatidylinositol in Plasma from Patients with Ovarian Cancer and Other Gynecological Diseases

By Shen Z.   Wu M.   Elson P.   Kennedy A.W.   Belinson J.   Casey G.   Xu Y.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 25-30

Elsevier

Access to resources Recommend Favorite